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The  presence  of  the  thymus  in  mice  is  essential  for  proper  development, 
maintenance,  and  function  of  the  lymphoid  system  (1,  2).  Thymic  function 
results from the interaction of peculiar cellular migration patterns to and from 
the thymus  (3-10)  and from the inductive or expanding capabilities of thymic 
stroma that include humoral factors (11,  12). 
In previous studies, we have shown that nonlymphoid thymomas induced restora- 
tion of immunological functions in neonatally thymectomized mice (13). When thymo- 
mas were grafted into allogeneic hosts, immunological restoration was mediated by 
lymphoid cells of host type (14). Thymomas and normal thymus were also capable of 
inducing restoration when enclosed in truly cell-impenetrable diffusion chambers (12). 
This evidence indicated that humoral inducing and/or expanding functions of thymus 
or thymomas mediate the restoration of the thymectomized hosts. Comparable results 
were obtained with free thymus grafts, and although restoration was mediated mainly 
by host-type cells, a thymus-derived cell population could be detected (6-10). 
When the treatment of neonatally thymectomized hosts with thymomas or thymus 
grafts was delayed after neonatal thymectomy, a decrease in the restorative influence 
was observed (15).  These results indicate that a population of cells in the thymecto- 
mized hosts capable of responding to  the action of thymus or  thymomas decreased 
progressively with  time after neonatal  thymectomy in absence of  thymic function, 
when the mice were nursed in a conventional environment (15). This decrease was in- 
terpreted as a  result of physiological attrition of cells differentiated prior to thymus 
extirpation (15). 
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The present report represents the attempts  to characterize this population of 
cells by employing combined treatment  of thymectomized  animals with thymic 
function (thymoma  or thymus)  together with cells of various origins. Our pres- 
ent results indicate that a  differentiated thymic-dependent  cell is present in the 
lymphohemopoietic  tissues  of  adult  and  newborn mice  and  is  sensitive to  the 
humoral  action of the thymus. 
Materials and Methods 
Animals.--Inbred mice of the A, C3Hf, DBA/2, CBA/H, C57BL/1, and T6 strains and F1 
hybrids of some of those strains were used. Animal care was as described in a previous paper 
(14). These mouse strains are derived from the colonies of Doctors J. J. Bittner and C. Marti- 
nez.  A  detailed  description of  the strains has been reported  recently  (16)  and  designed as 
University of Minnesota colony sublines (Umc). 
All the adult cell donors were £0-day old females. Thymus graft donors were 20-day old. 
Newborn cell donors were less than 24 hr old. 
Technical Procedures.--Techniques for  neonatal  thymectomy,  thymoma  grafting,  skin 
grafting, and preparation of cell SUsFensions have all been described in previous publications 
(8, 14). 
Bone marrow cells were obtained by flushing cold buffered Ringer's solution through long 
bones with hypodermic  syringes and 27-gauge  needles,  after clipping both bone ends with 
scissors. 
Thoracic duct cells were obtained from the subdiaphragmatic thoracic duct by the method 
described by Mandel (17),  and the 18-24 hr drainage was collected in siliconized glass tubes 
containing 10% fetal calf serum in Ringer's solution and 1 #g/ml of preservative free heparin. 
The total number of cells drained per mouse was 50-80 X  106 cells. 
Blood leukocytes were obtained from buffy coats from heparinized microcentrifuge tubes 
after centrifugation at 2000 rpm. 
Peritoneal cells were obtained after intraperitoneal injection of 5 ml of Ringer's solution as 
described by Goodman  (18).  With this technique the number of cells obtained per mouse is 
2-4 X  l0  G  cells, and approximately 60% are lymphoid cells. 
Peyer's patches were cut with scissors from the intestine and suspensions were prepared in 
glass homogenizers using a  standard  technique  (7,  8).  Since the patches were usually con- 
taminated with intestinal contents, the fragments were repeatedly washed before preparation 
of the cell suspension, and all the procedure was performed using Ringer's solution with the 
addition of 100 units of penicillin and 0.1 mg streptomycin/ml. 
Diffusion chambers were prepared with lucite rings and Millipore filters of 0.22 #  average 
pore size  (Millipore Filter Corp.,  Bedford, Mass.).  Details and descriptions of the chambers 
have been reported previously (12). 
Graft-versus-host assays were performed using 10 million spleen cells from the A or C3HI 
mice injected intraperitoneally into 8-day old  (AxC57BL)FI  and  (C3HxC57BL)Ft  hybrids, 
respectively. Spleen indices were obtained 8 days later as described in previous publications, 
and the negative controls were injected with syngeneic FI spleen cells (8,  14).  Discriminant 
spleen assays (8, 14) were performed for C3Hf cells using (C3HxC57BL/1)Fl and (C3HxT6)F1 
hybrids injected with 20 X  106 spleen cells from the test animals. 
Tests for delayed hypersensitivity to sheep red cells were used, as described in a previous 
paper (12) and the footpad volume increase was measured as described by Axelrad (19). 
Chromosome preparations were made as described in a previous paper (12, 20),  1 hr after 
the intraperitoneal administration of 0.02 ml/gm, body weight of a 0.004% solution of vinca- 
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Thymomas.--Two functional  thymomas (strain A thymoma  and  C3H  thymoma No.  2) 
appearing 200 days after neonatal intrathymic application of 0.1 mg of 7,12-dimethylbenz- 
anthracene were used.  Histological  characteristics,  growth patterns, and functional studies 
have been described in previous papers (13, 14). 
Restoration Criteria.--Neonatally  thymectomized mice were considered restored when they 
fulfilled all the following criteria for restoration: (a) complete thymectomy at the termination 
of the experiment  (microscopic analysis of the mediastinal contents);  (b)  200 day survival; 
(c) capacity to reject DBA/2 skin in less than 15 days when grafted at 90-100 days of age 
(normal rejection time in C3Hf animals is 12.3 +  1.3 and in A strain is 11.6 4- 1.5); (d) capac- 
ity to produce delayed hypersensitivity to sheep red cells when tested at 150-160 days of age 
(footpad volume increase of at least 15% when measured 48 hr after challenge with antigen); 
and (e) capacity of 10 X  106 spleen cells to produce a positive graft-versus-host  reaction when 
injected into appropriate F1 hybrids. This last test was not performed  when F1 hybrid cells 
were used for restoration (see Tables II and VI). The presence of all five criteria was essential 
for considering a particular animal restored. 
Experimental Design.--The basic experimental model consisted  of neonatally thymecto- 
mized mice treated at 45 days of age. Treatment consisted of thymic function (either thymoma 
grafts or thymus within cell-impenetrable  diffusion chambers)  and the intraperitoneal injec- 
tion of lymphohemopoietic  cells of various types. Controls received either thymic function or 
cells alone. The injected cells, except in experiments  where  the contrary is indicated, were 
always  syngeneic with the host. After treatment, the animal's testing for restoration was 
begun at 90-100 days of age, that is 45-55 days after treatment. 
RESULTS 
Association of Strain A  T hymoma and Adult Lym  phohemopoietic Cells.--T  able 
I  shows the incidence of restoration of 45-day old, neonatally thymectomized 
strain A and C3Hf mice treated with both strain A thymoma grafts and lympho- 
hemopoietic cells of a  variety of sources from 60-day old normal donors,  syn- 
geneic for the host. In both strains, thymoma grafts or cells alone were ineffec- 
tive, or only low percentages of restoration were observed with the cell dosages 
tested. Restoration was observed in small numbers  of animals, approximately 
10%, treated with thymoma alone or with spleen, lymph node, or thoracic duct 
cells. Bone marrow cells were ineffective by themselves, even when  150 million 
syngeneic cells were used.  For comparison it can be  seen in Table I  that  the 
same number of syngeneic spleen cells produced high incidence of restoration. 
The  other  cell types  tested  were  thymus,  blood leukocytes, peritoneal cells, 
adult liver cells, and Peyer's patch cells. All these cell types were ineffective in 
producing significant restoration at the cell dosages employed. 
On  the contrary,  the  association of thymoma  and  cells, especially marrow, 
spleen, thymus, lymph node, thoracic duct, and blood leukocytes, was effective 
in favoring immunological restoration of the thymectomized hosts. 
In the A strain mice (Table I, column 4), restoration was observed in 46 of 72 
animals treated with  thymoma plus spleen cells (63%),  22  of 48  treated with 
thymoma and bone marrow cells (45 %), and 15 of 58 treated with thymoma and 
thymus cells (25%),  expressed as combined results of the different cell dosages 
tested  (50,  20,  10,  and  5  X  106).  Lymph  node  cells and  blood leukocytes in 586  STUDIES  ON  THYMUS FUNCTION.  I 
TABLE  I 
Restoration of 45-day Old, Neonatally Thymectomized A and C3Hf Mice with Strain A Thymoma 
and Lymphohemopoietic Tissues from Adult Donors Syngeneic to the Host 
Treatment*  Number restored per number treated 
Tumor graft  Cells  Cell type  A strain  C3Hf strain 
× 10~,  %  % 
None  None  --  0/20  0/23 
A thymoma  None  --  4/32  (12)  2/19  (10) 
None  150  marrow  0/20  0/25 
None  50  marrow  0/12  0/11 
None  20  marrow  0/13  0/15 
None  10  marrow  0/12  0/10 
None  150  spleen  8/10  (80)  9/10  (90) 
None  20  spleen  2/20  (10)  1/12  (8) 
None  10  spleen  1/12  (8)  1/16  (6) 
None  5  spleen  3/31  (9)  1/16  (6) 
None  50  thymus  1/18  (5)  0/10 
None  20  thymus  0/12  1/12  (8) 
None  10  thymus  0/12  0/13 
None  20  lymph node  0/10  1/10  (10) 
None  20  thoracic duct  ND  2/16  (12) 
None  20  blood leukocytes  ND  1/20  (5) 
None  20  pe;itoneal cells  ND  0/10 
None  20  liver cells  ND  0/12 
None  20  Peyer's patches  ND  0/10 
A thymoma  50  marrow  6/10  (60)  6/12  (50) 
A thymoma  20  marrow  6/12  (50)  4/12  (33) 
A thymoma  5  marrow  10/26  (37)  4/16  (25) 
A thymoma  20  spleen  14/20  (70)  22/40  (55) 
A thymoma  10  spleen  20/31  (64)  8/16  (50) 
A thymoma  5  spleen  12/21  (57)  11/27  (41) 
A thymoma  50  thymus  6/18  (33)  5/13  (38) 
A thymoma  20  thymus  6/18  (33)  10/30  (33) 
A thymoma  10  thymus  3/22  (16)  5/22  (22) 
A thymoma  20  lymph node  6/10  (60)  20./40  (50) 
A thymoma  20  thoracic duct  ND  5/10  (50) 
A thymoma  20  blood leukocytes  3/10  (30)  4/12  (33) 
A thymoma  20  peritoneal ceils  2/20  (10)  I//12  (8) 
A thymoma  20  liver cells  ND  2//16  (12) 
A thymoma  20  Peyer's patches  ND  3/16  (18) 
* Neonatally thymectomized A  and  C3Hf mice, treatment performed at 45  days of age. 
Tumor grafts as subcutaneous implantation of 1 X  106 cells. Cells as intraperitoneal injection 
simultaneous with tumor grafting. Donors were 60-day old A or C3Hf females respectively, 
syngeneic for the host strain. For restoration criteria see text. 
association  with  this  strain  A  thymoma  gave 60  and  44%  restoration,  respec- 
tively, while peritoneal cells were ineffective. 
Comparable  results  were  obtained  with  C3Hf  thymectomized  hosts  treated 
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normal adult  C3Hf donors.  Table I  (column 5)  shows that  the  association of 
thymoma and  cells produced  significant number of restorations.  By contrast, 
animals treated with thymoma or cells alone were not restored. Restoration was 
observed in 41 of 83 mice treated with thymoma plus spleen cells (49%),  14 or 
40 treated with thymoma and bone marrow cells (35%),  and  20 of 65 treated 
with  thymoma and  thymus  cells  (30%).  The majority of  the  restored  C3Hf 
animals eventually rejected the strain A thymoma after its temporary growth, 
and only 11 of a total of 80 restored animals receiving tumor grafts and spleen, 
marrow, or thymus cells accepted the thymoma for 60 days or more after graft- 
ing. These results were similar to those previously reported (14). In this system 
TABLE  II 
Restoration of 45-day Old, Neonatally  Thymectomized C3Hf Mice Treated with  Strain  A 
Thymoma and Spleen Cells from Adult F1 Hybrids* 
Number restored  Acceptance Acceptance  of A  Tumor graft  Cell donors  per number treated  thymoma~  of A skin~ 
% 
A thymoma  --  1/12  (8)  1/1  0/1 
None  (C3H X A)F1  0/10  --  -- 
None  (C3H X C57BL/1)F1  1/12  (8)  --  -- 
None  (C3H)< T6)F1  0/12  --  -- 
A thymoma  (C3H X A)F1  9/20  (45)  9/9  9/9 
A thymoma  (C3H X C57BL/1)F1  12/25  (47)  0/12  0/12 
A thymoma  (C3H X T6)Fx  11/20  (55)  1/11  0/11 
* Neonatally thymectomized C3Hf mice, treatment  performed at 45 days of age. Subcu- 
taneous implantation of 1 )<  106 tumor cells. Intraperitoneal  injection, simultaneous with 
tumor grafting of 10 )< 106 cells. Donors were 60-day old F1 hybrid females. 
:~ Acceptance for 20 days or more after grafting. Skin grafting performed at 90 days of age. 
Number of animals accepting graft per number grafted. 
C3Hf lymph node and  thoracic duct lymphocytes and blood leukocytes were 
also effective in producing restoration when they had been given to C3Hf recipi- 
ents in association with the strain A thymoma. Peyer's patches gave borderline 
effects, while peritoneal cells and adult liver cells were ineffective when given in 
association with the strain A thymoma. 
Table II shows restoration  of 45-day old,  neonatally thymectomized C3Hf 
mice treated with strain A thymoma plus 10 X  106 spleen cells from three differ- 
ent normal adult F1 hybrids. Restoration was 45, 47, and 55 % respectively for 
mice treated with thymoma and spleen cells of (C3HxA) F1, (C3HxC57BL/1) F1, 
and  (C3HxT6)F1  hybrids.  As  would  be  predicted  if  restoration  is  mediated 
by  expansion  of  the  injected  spleen  cell  population,  the  mice  restored  with 
(C3HxA)F1 cells accepted the  strain  A  thymoma and  A  strain  skin, whereas 
animals restored with the other F1 hybrid combinations rejected strain A  thy- 
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were capable of rejecting DBA/2 skin within normal time limits (see restoration 
criteria). 
A special group of 45-day old, neonatally thymectomized C3Hf mice treated 
with strain A thymoma and spleen cells from (C3HxT6)F1 hybrids was studied, 
and chromosome preparations of their lymphohemopoietic tissues are shown in 
Table III. Chromosome preparations were made at  10,  30,  60,  and  155  days 
after  treatment,  and  all  animals  (with  exception  of  the  10-day group)  were 
capable of rejecting DBA/2 skin grafts within normal time limits when grafted 
TABLE  III 
Chromosome Analysis of Lymphohemopoietlc Tissues of 45-day Old, Neonatally Thymectomized 
C3Hf Mice Treated with Strain A  Thymoma and Spleen Cells  from Adult 
(C3H X  T6)F1 Hybrids 
Days  Spleen  donor type metaphases per total metaphases 
after  Mesenteric  Peyer's  Thy-  treatment*  Spleen  Bone marrow  Axillary nodes  nodes  patches  morea 
10  57/111 (51)  10/32 (31)  19/22  (86)  6/14  (42)  1/30 (3)  1/40 
30  98/142 (67)  9/32  (28)  72/74  (97)  20/33 (66)  1/30 (3)  3/8 
60  83/155 (53)  8/91  (8)  44/50  (88)  5/16  (88)  1/23 (4)  ND 
155  60/106  (56)  13/48 (27)  26/27  (96)  12/14  (96)  2/22  (9)  ND 
* Neonatally thymectomized C3Hf mice, treatment performed at 45 days of age and con- 
sisted of subcutaneous injection of 1 X  106 strain A thymoma cells and intraperitoneal injec- 
tion of 10 X 106 spleen cells  from 60-day old, normal (C3H X T6)F1 hybrid females.  Animals 
received DBA/2 skin grafts  15 days after treatment.  Chromosome preparations made one 
hour after Velban administration. Four animals per group, and the results are expressed as 
combined data for each tissue. Per cent of spleen type per total metaphases in parentheses. 
15 days after treatment. In this experiment, as well as in a  similar experiment 
performed  using  newborn  (C3HxT6)F1  hybrid  liver  cells,  the  only immuno- 
logical parameter tested for restoration was the rejection of DBA/2  skin. The 
results of the 30-day group represent animals that had rejected a  skin graft a 
few days before. Since there was small variation for the individual values for 
each group, the results are presented as pooled data from four animals. Table III 
shows that a  substantial portion of cells, especially in lymph nodes,  have the 
karyotype characteristics of the spleen-cell donor (positive for the small auto- 
somal T6 marker). The per cent of spleen-type metaphases in different tissues 
was  approximately 51-67  for  spleen,  30  for  marrow,  86-97  for  axillary  and 
cervical nodes, 42-96 for mesenteric node, 3-9 for Peyer's patches, and 2-37 for 
the  thymoma graft. If considered in relation to time after treatment,  the per 
cent of spleen-type metaphases was fairly constant in spleen, marrow, axillary 
nodes,  and  Peyer's patches  and  increased  progressively in  mesenteric  nodes. 
The low percentage of donor cells in the marrow at 60 days (8%) is difficult to 
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(97 %)  at day 30 must be related  to skin graft rejection,  since the grafts were 
applied  on areas drained  by those  nodes.  The high incidence  (37 %)  of donor 
cells in the  thymoma at day 30,  although  a  small  sample,  may represent  the 
events leading to ultimate  rejection of the  tumor graft.  These results  suggest 
that adoptive restoration of the thymectomized host by the injected spleen cel[s 
TABLE IV 
Discriminant Spleen Assays in Neonatally Thymectomized C3ttf Mice Treated at 45 Days of Age 
with Strain A  Thymoma and Spleen Cells  from Adult donors 
Experimental groups* 
Test litters and spleen indexes:~ 
(C3H X  C.~TBI/I)F1  (C3H X T6)FI 
A thymoma and  (C3H)<  T6)F1 spleen cells 
(10) 
0.98, 1.01, 1.01,  1.03, 0.88, 1.12, 
1.03, 1.10, 1.13,  1.20, 1.01, 1.16, 
1.16, 1.17, 1.20,  1.02, 0.99, 1.00 
1.67  1.02 
A thymoma and C3Hf spleen cells (9)  1.55, 1.69, 1.80,  1.47, 1.88, 2.C0, 
1.81, 1.88, 1.89,  1.66, 1.90, 1.66, 
1.90, 1.95, 2.02  2.00, 1.79, 1.88 
A thymoma (10)  0.90, 1.00, 1.01,  1.00, 1.10, 0.99, 
1.05, 1.07, 1.10,  1.12, 1.00, 1.03, 
1.11, 1.13, 1.35  1.10, 1.17, 1.40, 
1.69  1.55 
Normal C3Hf (29)§  2.89 (2.10-3.00)  2.00 (1.75-2.90) 
* Neonatally  thymectomized  C3Hf mice treated  at 45 days of age with  a subcutaneous 
thymoma graft and 10 )<  106 spleen cells of (C3H X T6)F1 or C3Hf 60-day old, normal fe- 
males. Discriminant test performed 40 days after treatment.  Numbers in parentheses indicate 
number of animals tested. Results are paired for each individual mouse tested  (i..e, 0.98 and 
1.03 in the first group, etc.) 
Positive index higher than 1.30. All hybrid litters were 8 days old and given intraperi- 
toneal injections of 20 )< 106 spleen cells. Negative controls received syngeneic spleen cells. 
§ Spleen indexes expressed as mean and range. 
occurs, but  the experiment does not differentiate  dividing  cells  and immuno- 
logically competent cells. 
The host-type immunological component  (C3Hf)  was assessed  using a  dis- 
criminating spleen assay described in previous publications (8, 14). Test animals 
were  (C3HxC57BL/1)F1  and  (C3HxT6)F1  hybrids  injected  with  20  X106 
spleen cells from the restored animals. Host-type competent cells were detected 
in one of 10 animals  studied 40 days after treatment  with strain A  thymoma 
and  (C3HxT6)F1  spleen  cells  (Table  IV). In that only case,  the host  (C3Hf) 
cells were specifically tolerant to the (C3HxT6)F1 while they were detected in 
the  (C3HxC57BL/1)Fv  For  comparison,  nine  animals  were  tested  in  which 590  STUDIES  ON  THYMUS  FUNCTION.  I 
restoration was produced by the  strain A  thymoma plus spleen cells of C3Hf 
origin. The spleen index test revealed the C3H component in all the instances 
(Table IV). Table IV also shows that of 10 animals treated only with the strain 
A  thymoma, the host  (C3Hf)  component was detected in only two animals, a 
result compatible with the incidence of restoration revealed in the earlier studies 
(Table I). 
TABLE V 
Restoration of 45-day Old, Neonatally Thymectomized C3Hf Mice u4th C3Hf Thymus" within 
Diffusion Chambers and Lymphohemopoietic Tissues  from Adult Syngeneic Donors 
Number  number  Treatment*  Cells  res~or~ ~,er 
treated 
X  10~  % 
None  None  0/19 
Bone marrow  50  4/18  (50) 
Bone marrow  20  3/12  (25) 
Bone marrow  5  1/10  (10) 
Spleen  20  6/10  (60) 
Spleen  5  4/12  (33) 
Thymus  50  4/12  (33) 
Thymus  20  5/20  (25) 
Thymus  5  2/20  (10) 
Lymph node  20  4/8  (50) 
Thoracic duct  20  4/8  (50) 
Blood leukocytes  20  3/10  (30) 
Peritoneal cells  20  1/10  (10) 
Peyer's patches  20  1/12  (8) 
* Neonatally thymectomized C3Hf mice treated at 45 days of age with a C3Hf thymus 
lobe from a 20-day old donor enclosed within a diffusion chamber (0.22/~ pore size) implanted 
intraperitoneally and injection of lymphohemopoietic  cells from 60-day old syngeneic female 
donors. 
These results support the view that the immunological restoration of 45-day 
old, neonatally thymectomized C3H mice treated with strain A  thymoma plus 
adult  spleen  cells is  adoptively mediated  by  expansion  mainly of the  spleen 
donor population. 
Association  of Thymus  Within Di~usion  Chambers  and Adult  Lymphohemo- 
poietic Cells.--Table V shows the restoration of 45-day old, neonatally thymec- 
tomized C3Hf mice with syngeneic thymus within diffusion chambers and the 
association  of lymphohemopoietic cells from syngeneic  adult  donors.  As was 
shown in  a  previous publication  (15),  thymus grafts within  cell-impenetrable 
chambers are incapable of restoring neonatally thymectomized mice when the 
treatment is performed at 45 days of age. On the other hand, the association of 
intraperitoneal  diffusion  chambers containing  one thymus lobe of  20-day old 
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syngeneic lymphohemopoietic  organs  was  effective.  The  combined  results  of 
different cell dosages show that bone marrow produced 20%  restoration  (8 of 
40),  spleen 45%  (10 of 22),  and  thymus 21%  (11  of 52).  As in the  thyrr_oma 
experiments  (Table I) lymph node and thoracic duct cells were effective, pro- 
TABLE VI 
Restoration of 45-day Old, Neonatally Thymectomized C3Itf Mice with Strain  A  Thymoma and 
Liver, Spleen, or Thymus Cells  from C3Hf Newborn Mice 
Treatment* 
Graft  Ceils  Cell  type 
Number restored  per 
number treated 
X  10~  % 
None  None  --  0/10 
A thymom  a  None  --  2/22  (10) 
None  100  liver  0/16 
None  50  liver  0/15 
None  20  liver  0/11 
None  5  liver  0/20 
None  100  spleen  0/18 
None  50  spleen  0/10 
None  20  spleen  0/13 
None  5  spleen  0/12 
None  100  thymus  0/10 
None  50  thymus  0/12 
A thymoma  100  liver  5/10  (50) 
A thymoma  50  liver  13/23  (56) 
A thymoma  20  liver  7/17  (41) 
A thymoma  5  liver  4/20  (20) 
A thymoma  100  spleen  5/10  (50) 
A thymoma  50  spleen  4/9  (44) 
A thymoma  20  spleen  5/9  (55) 
A thymoma  5  spleen  4/13  (31) 
A thymoma  50  thymus  20/30  (66) 
A thymoma  20  thymus  7/17  (41) 
A thymoma  5  thymus  2/10  (20) 
* Neonatally thymectomized  C3Hf mice, treatment  performed at 45 days of age. Subcu- 
taneous  graft of 1 X  106 tumor cells. Intraperitoneal  injection,  simultaneous  with tumor 
grafting, donors were C3Hf mice less than 24-hr old. 
ducing 50 %  restoration, and blood leukocytes produced 30 %  restoration. Peri- 
toneal cells  and Peyer's patch cells produced some degree of restoration  with 
10 and 8%, respectively. 
Association  of Strain A  Thymoma  and Newborn  Lymphohemopoietic  Cells.- 
Table VI  shows the  effects  of treatment  with  strain  A  thymoma  and  liver, 
spleen or thymus cells from C3Hf newborn donors on restoration of 45-day old, 
neonatally thymectomized C3Hf mice. As in the experiments using cells derived 
from adults (Table I), restoration was observed only when thymoma grafts and 592  STUDIES  ON  THYMUS  FUNCTION.  I 
cells  were  administered  together.  The  combined  results  for the  different cell 
dosages  tested  indicate  that  restoration  was  observed  in  29  of  70  animals 
treated with hemopoietic liver cells  (41 ?/~), 18 of 41 treated with spleen (43 %), 
and 29 of 57 treated with newborn thymus cells  (50~). If only one cell dosage 
is compared (50  X  106), restoration was 66%  for thymus, 56% for liver, and 
44% for spleen.  These results contrast with those using adult cells in combina- 
tion with  thymoma in which  the most effective cells  were  spleen,  and  com- 
parable  dosages of marrow or thymus cells  produced 50 and 38%  restoration 
respectively (Table I). The combined results for all cell dosages of adult thymus 
cells plus thymoma grafts indicate 25 %  (15 of 58)  restoration for the A strain 
TABLE VII 
Restoration of 45day Old Neonatally Thymectomized C3Hf Mice with Strain A  Thymoma and 
Liver Cells  from Newborn F1 Hybrids* 
Number restored  Acceptance  Acceptance 
of A  Tumor graft  Cell donors  per number treated  thymoma:~  of A skin~ 
% 
None  (C3H X A)F1  0/20  --  -- 
None  (C3H X C57BL/1)F1  0/22  --  -- 
None  (C3H M T6)F1  0/16  --  -- 
A thymoma  (C3H X A)F1  8/17  (47)  8/8  8/8 
A thymoma  (C3H X C57BL/1)F1  14/32  (43)  1/14  0/14 
A thymoma  (C3H X T6)F1  10/20  (50)  1/10  1/10 
* Neonatally thymectomized  C3Hf mice, treatment performed at 45 days of age. Subcu- 
taneous implantation of 1 X 106 tumor ceils and intraperitoneal injection simultaneous with 
tumor grafting of 50 X l06 liver cells from newborn F1 hybrid donors. 
Acceptance for 20 days or more after grafting. Skin grafting performed at 90 days of age. 
Number of animals accepting graft per number of grafted. 
and 30%  (20 of 65)  for the C3Hf when treated  with adult thymus (Table I). 
On the other hand, newborn thymus cells produced 50%  (29 of 57)  restoration 
(Table VI) even when smaller cell dosages were used (5 as opposed to 10 X  106 
cells as the lower dosage in the adult thymus exepriments). 
Table VII shows restoration produced by strain A thymoma and 50 X  l06 
liver cells from newborn donors of (C3HxA)F1, (C3HxC57BL)F1, and (C3Hx- 
T6)F1 origin. These results are comparable to the ones obtained with 10 X  106 
adult F1 spleen cells (Table II) or 50 X  106 syngeneic newborn liver cells (Table 
IV). As in the previous experiments  (Tables II-IV), the results  suggest that 
restoration is mediated by expansion of the donor cell population. 
Chromosome analysis of the peripheral lymph nodes of the animals injected 
with (C3HxT6)F1 liver cells 155 days after treatment indicated that 186 of 201 
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In a separate group of six animals restored with (C3HxT6)F1 newborn thymus 
cells and thymoma graft, the peripheral lymph nodes contained 99 of 101 meta- 
phases  of  thymus-donor type  at  155  days  after  treatment.  The  number  of 
donor-type metaphases in the bone marrow of the treated animals was 16 of 40 
for the animals treated with newborn liver and 5 of 63 for the animals treated 
with newborn thymus ceils in association with strain A thymoma. When these 
results are compared with the figures obtained 155 days after treatment with 
adult spleen cells (Table III), it can be seen that the proportions of donor cells 
in the peripheral axillary lymph nodes are comparable and higher than 90%. 
The results for bone marrow are different since the proportion of donor cells 
when the animals were treated with adult spleen was 27 %, as opposed to 40% 
for the animals treated with newborn liver and 7 % for the animals treated with 
newborn thymus. Other tissues were not studied. 
Host (C3Hf) component was studied with a discriminant spleen index assay 
in  (C3HxC57BL/1)F1 and  (C3HxT6)F1 hybrids. As in the  animals  restored 
with  adult  F1 hybrid  spleen  cells,  the  majority  of  the  mice  restored  with 
strain  A  thymoma  and  liver cells  from  newborn  (C3HxT6)F1  hybrids  did 
not show a detectable host component. When 10 such animals were tested 40 
days after treatment, the C3Hf component was detected in only two animals. 
As in the animals restored with adult spleen (Table IV) the C3Hf component 
was specifically tolerant to (C3HxT6)F1 and was detectable only in the (C3Hx- 
C57BL/1)F1 hybrid. 
The detection of cellular chimerism and the absence of a detectable immuno- 
competent component of host origin indicate that the restoration is mediated 
by the action of the thymoma on the iniected donor cells. 
Combination of Thymus with Bone Marrow or Liver Cells.--Table VIII shows 
the results obtained with the association of cell suspensions of thymus with adult 
bone marrow or newborn liver and subcutaneous grafts of strain A thymomas 
or C3Hf thymus grafts enclosed in cell-impenetrable chambers implanted intra- 
peritoneally. Whether adult or newborn thymus cells were used in combination 
with adult bone marrow or newborn liver alone or in association with thymoma 
grafts or thymus within diffusion chambers, no synergism was observed. The 
percentages of restored animals were comparable to the  ones observed with 
similar cell dosages by themselves or by the combined effect of both cell types 
(Table I, V, and VI). 
DISCUSSION 
Cellular and humoral components of thymus function (1-15)  and synergism 
between thymus and cells of other origins (21, 22) have been demonstrated, but 
the  significance of  these phenomena  under  physiological conditions  remains 
unknown. Despite these limitations the study of reconstituted animals, taken in 594  STUDIES  ON  THYMUS  FUNCTION.  I 
conjunction with previous work,  offers information about  the cellular basis of 
immunological development in the mouse and permits interpretations of these 
observations. 
For the present discussion of our results, the term "humoral activity" of the 
thymus will be applied to the type of restorative capacity observed with func- 
tional  thymoma  grafts  and  thymus  or  thymomas  housed  within  cell-impene- 
trable diffusion  chambers.  "Cellular activity"  will be  applied  to  the  type  of 
TABLE VIII 
Attempts  to  Show Synergism Between Thymus  and  Bone Marrow or  Newborn Liver Cells in 
Restoration of 45-day Old, Neonatally Thymectomized C3Hf Mice 
Number restored 
Treatment*  Cell numbers  per number 
treated 
X  10  r'  % 
Adult thymus +  bone marrow  20  +  20  0/16 
Adult thymus +  newborn  liver  20  +  20  0/14 
Newborn  thymus +  bone marrow  20  +  20  0/14 
Newborn thymus +  newborn  20  +  20  0/13 
Adult thymus +  bone marrow  20  +  50  0/12 
Adult thymus +  bone marrow  50  4-  50  0/10 
Adult thymus +  bone marrow  and strain A thymoma  20  -b  20  7/14  (50) 
Adult thymus +  bone marrow  and C3Hf thymus in D.C.  20  +  20  11/27  (41) 
Newborn  thymus +  bone marrow and strain A thymoma  20  4-  20  4/12  (33) 
Newborn  thymus +  bone mar;ow and C3HI thymus in D.C.  20  +  20  4/12  (33) 
Newborn thymus +  newborn liver and strain A thymoma  20  +  20  3/6  (50) 
Newborn thymus +  newborn liver and C3Hf thymus in D.C.  20  +  20  3/6  (50) 
Adult thymus +  newborn  liver and strain A thymoma  20  4-  20  2/6  (33) 
Adult thymus 4- newborn liver and C3Hf thynms in D.C.  20  4-  20  3/8  (37) 
* Neonatally thymectomized  C3Hf mice treated at 45 days of age with intraperitoneal in- 
jection of syngeneic thymus or marrow-liver cells derived from 60-day old females or newborn 
mice.  Thymoma  grafts were  subcutaneous  and  thymus  were  implanted intraperitoneally 
within diffusion chambers  (D.C.)  of 0.22 #  pore size. 
restoration capacity observed with viable thymus grafts and is meant to indicate 
the humoral activity and both  traffic of ceils to and from the thymus and the 
influence  of  the putative microenvironment  within  the  thymus  stroma which 
favors lymphoid maturation. 
In a previous publication, we postulated the existence in the peripheral lym- 
phohemopoietic tissues of the mouse of a population of cells capable of respond- 
ing, probably by proliferation, to the humoral activity of the thymus (15). This 
population is thymus  dependent in  the  sense that  continuous presence of the 
thymus is required for its renewal in animals reared in a  conventional environ- 
ment.  This population of cells decreases progressively with time in neonatally 
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physiological attrition and/or immunological commitment. This renewal proc- 
ess  may be  related  to  the  differentiative activity of  the  thymus, mediated 
through its cellular traffic. 
Our present experiments indicate that when adult lymphohemopoietic cells 
are used in cooperation with thymic humoral activity, restoration of 45-day old, 
neonatally thymectomized mice can be achieved with cell numbers that will be 
ineffective by themselves. If a particular cell dosage is analyzed (i.e.,  2 X  107, 
see  Table  I),  the  effectivity for restoration when given in  association with 
functional thymoma grafts in decreasing order is the following: spleen, lymph 
nodes,  thoracic  duct,  bone  marrow,  thymus, blood leukocytes, and  Peyer's 
patch cells. 
When the same comparison was made for the association of cells with thymus 
within impenetrable chambers for the same dosage (2 X  10  T) of cells (see Table 
V),  effectiveness in restoration in decreasing order was: spleen, lymph node, 
thoracic duct, blood leukocytes, bone marrow, thymus, peritoneal cells,  and 
Peyer's patch cells. 
It can be proposed and supported by the present data that a certain popula- 
tion of lymphoid cells widely distributed in the lymphohemopoietic tissues of 
young adult mice is sensitive to humoral expansion by the thymus. Our results 
indicate that this cell population is present in different concentrations in the 
tissues studied with largest numbers in the peripheral lymphatic tissues (spleen, 
lymph nodes, and thoracic duct). Cell numbers are estimated indirectly on a 
functional basis, assuming that restorative effect of the cells in association with 
thymic function is proportional to the number of "sensitive" cells present in the 
inoculum. Bone marrow contains not only this population of cells, but also the 
cell type capable of thymus traffic in the adult mouse (5), which has been con- 
sidered the true prethymic precursor (23).  Our results also indicate that bone 
marrow does not contain competent cells capable of restoring thymectomized 
animals by themselves in absence of thymus. Even 1.5 X  l0  s syngeneic marrow 
cells were ineffective when tested in 45-day old, neonatally thymectomized A 
or C3Hf mice (Table I). These results contrast with the effectiveness of spleen 
and other lymphoid tissues in restoring neonatally thymectomized mice (8, 20). 
The presence in the blood and thoracic duct of cells capable of cooperative 
effect when associated with thymic function (Table I) suggests that they can be 
mobilized according to demands. Preliminary work indicates an increase of this 
circulating cell in blood following 500 R  of whole body irradiation (Stutman, 
unpublished  observations).  On  the  other  hand,  the  cell  that  is  sensitive  to 
humoral activity of the thymus is absent from peritoneal and adult liver cell 
populations. 
When Peyer's patch c~lls, containing mainly small lymphocytes, were tested, 
the results were borderline (Tables I  and V)  and could be accounted for by 
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of peritoneal cells seen in Table V). Two other interpretations can be proposed 
for the relative lack of influence of Peyer's patch cells in this regard. One is that, 
if their lymphoid cells  are  comparable  to  the  avian bursa  (24),  they might 
contain precursors for the antibody-producing series and not for the population 
responsible for cell-mediated immunity that was analyzed in the present work. 
On  the  other  hand,  this population  could  also  represent  highly immunized 
peripheral lymphoid tissue, already committed immunologically and incapable 
of further differentiation (25). Preliminary work suggests that the latter possi- 
bility may indeed be correct since spleen cells from adult animals hyperimmu- 
nized with brucella antigen are less effective using the present model, as com- 
pared to nonimmunized spleen cells (Stutman, unpublished observations). 
The mechanism of this cooperation between cells  and the thymic humoral 
activity in producing restoration of thymectomized mice seems to be related to 
proliferative expansion of the injected cells. Tables II-IV indicate the results 
obtained with FI hybrid cells in association with thymoma grafts. These results 
strongly support the view that restoration is achieved by establishement of the 
transplanted population of cells and its proliferative expansion. This is indicated 
by the specific  tolerance for grafts of the other parental type (Tables II and 
VII),  by chimerism reflected by chromosome analysis showing spleen-donor 
type cells throughout the lymphatic tissues of the host in numbers greater than 
could be attributed to the original inoculum (Table III),  and by absence of 
significant immunocompetence  attributable  to  the  host  in  graft-versus-host 
assays (Table IV). 
Comparable results were obtained when similar experiments were performed 
using cells from newborn animals. Newborn spleen, hemopoietic liver or thymus 
cells in association with the strain A thymoma, produced significant restoration 
of neonatally thymectomized 45-day old recipients. If a particular cell dosage is 
compared (2 X  107), the effectiveness in restoration was 55, 41, and 41% respec- 
tively for spleen, liver, and thymus. When compared to the same dosage of adult 
cells, newborn thymus had greater activity than that of the adult (Tables I and 
VI). These results suggest that the newborn thymus contains higher numbers of 
possible competent cells than does the adult thymus, cells that are probably in 
the  process  of  acquiring  the  ability  to  migrate  to  the  lymphohemopoietic 
tissues but are already sensitive to the humoral activity of the thymus. Hemo- 
poietic newborn liver was slightly more effective than was adult bone marrow, 
while the results for spleen were comparable. This last point is of interest be- 
cause it indicates that the content of cells  capable of cooperative restoration 
when associated with humoral thymic function is similar in newborn and adult 
spleen,  while it is known that the content of mature competent cells capable of 
producing graft-versus-host reactions is almost absent  from  newborn  spleen 
(26).  Comparable results have been obtained when newborn cell inocula were 
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When F1 hybrid newborn liver cells were used (Table VII)  the results indi- 
cated that proliferative expansion of the injected population of cells mediated 
the restoration. 
Since a peculiar synergism between thymus and bone marrow cells has been 
described for some immune responses (21, 22), the effect of combining dispersed 
thymus cells and bone marrow or newborn liver cells was studied. Table VIII 
shows that no particular synergism between these cell types was observed when 
the cells were given in  association with either strain A  thymoma  or thymus 
grafts in diffusion chambers. An absence of such synergism for graft-versus-host 
cell-mediated  immunity  has  previously  been  described  when  thymus-bone 
marrow  combinations  (29,  30)  or thymus-fetal liver combinations were used 
(31). On the other hand, fetal liver can act synergistically with thymus cells for 
the humoral response to sheep red cells (32). 
In previous publications, we proposed a model that fits with the present data 
(15, 27). We postulated that the population of cells present in the lymphohemo- 
poietic tissues of newborn or adult animals, capable of cooperative restoration 
when associated with humoral activity of the thymus, represents a population 
of cells that has received thymic influence before thymectomy was performed. 
The humoral activity of the thymus can expand solely such  a  population of 
"postthymic" cells in the peripheral tissues of the host. The word "expand" is 
used here to indicate proliferation and/or also a  differentiative process even- 
tually leading to a larger number of fully competent cells. At the present writing 
the words "humoral," "expander," and "inducer" are used as operational terms, 
since the evidence for a true hormonal lymphopoietic effect of the thymus is still 
unclear (33). 
We also suggested that the population of postthymic cells was incapable of 
self-renewal in absence of the thymus and that the process by which this popu- 
lation was replaced included traffic of hemopoietic stem cells to the thymus (15). 
We have shown that embryonic hemopoietic tissues do not contain postthymic 
cells capable of cooperative restoration when associated with humoral activity 
of the thymus (27, 28). The embryonic hemopoietic tissues, however, contain a 
cell  population  that  we  termed  "prethymic,"  population  characterized  by e 
capacity to traffic to thymus and bone marrow (34)  and which is insensitive to 
the humoral activity of the thymus (27,  28). 
The ontogeny of lymphoid development may be interpreted as a result of both 
processes: first a build up of the postthymic population by traffic of hemopoietic 
stern cells through thymic stroma during the final stages of embryonic develop- 
ment and first days after birth, and further expansion of the postthymic popu- 
lation by humoral activity of the thymus. The maintenance of the postthymic 
population seems to be dependent on a continuing traffic of bone marrow cells 
to thymus, as well as the expanding influence of the thymic humoral function. 598  STUDIES  ON  THYMUS  FUNCTION.  I 
SUMMARY 
Immunological restoration  of 45-day old,  nconatally thymcctomized  C3Hf 
mice by treatment with humoral thymic function (thymoma grafts,  thymus or 
thymoma in  diffusion  chambers) ranges  from  0  to  12  %  and  is  difficult  to  achcive. 
When small  numbers (5-20 X  10  s) of young adult  lymphohcmopoictic  cells, 
ineffective  by themselves, are given in association  with humoral thymic func- 
tion, a cooperative effect  is observed and restoration  ranges from 30 to 60%. 
With a  particular  cell  dosage (20 X  I0~),  effectivity  for  cooperation  with thymic 
function was the following  in decreasing  order:  spleen,  lymph nodes,  thoracic 
duct cells,  bone marrow, blood Icukocytes,  thymus, and Peyer's  patch cells. 
Comparable results  were obtained using  spleen,  thymus, and hcmopoietic liver 
from newborn  donors in association  with thymic function.  For similar  ce]l 
dosages,  newborn thymus cells  were more effective  than adult  thymus in their 
cooperative  effect  with thymic function.  Dispersed thymus cells  in association 
with young adult  bone marrow or newborn hemopoietic liver  cells  showed no 
synergism for  the  cooperative  effect  with thymic function  in  the  present  mode]. 
Using  hemiallogeneic  cells  (FI  hybrid into  parent)  it  was  possible  to  show that 
restoration  was mediated by proliferative  expansion of the injected  cells.  This 
was  indicated  by specific  tolerance  to  tissues  of  the  other  parental  strain  and by 
cellular  chimerism, especially  of  lymphoid tissues,  as  indicated  by chromosome 
markers and absence of significant  numbers of  immunocompctent  cells  of host 
origin. 
A  population of paritally  differentiated  cells  of hemopoietic origin,  termed 
postthymic, sensitive  to humoral activity  of the thymus and present  in the 
lymphohemopoietic tissues  of adult  and newborn mice is  postulated to explain 
our  results.  These cells  are  postthymic and thymus dependent in  the  sense  that 
they  already  received  thymic influence,  probably through traffic,  and are  incap- 
able  of  self-renewal  in  absence of  the  thymus. Sensitivity  to  humoral activity  of 
the thymus is  characterized  by proliferative  expansion and/or a differcntiative 
process  eventually  leading  to  larger  numbers of  competent cells. 
The authors  wish  to thank  M. J.  O'Connor,  J.  M. Smith,  A. Hanson,  and C. Baker  for 
their  able  assistance. 
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